2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference
- PMID: 21543936
- DOI: 10.1097/IGC.0b013e31821b2568
2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference
Abstract
2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer. This report provides the outcomes from the Fourth Ovarian Cancer Consensus Conference.
Similar articles
-
The global impact of the Gynecologic Cancer InterGroup in enhancing clinical trials in ovarian cancer.Int J Gynecol Cancer. 2011 May;21(4):746-9. doi: 10.1097/IGC.0b013e31821bb446. Int J Gynecol Cancer. 2011. PMID: 21543935
-
American Society of Clinical Oncology 2012 Annual Meeting: highlights from the gynecologic oncology track.Int J Gynecol Cancer. 2012 Nov;22(9):1634-9. doi: 10.1097/IGC.0b013e318270febe. Int J Gynecol Cancer. 2012. PMID: 23095779
-
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors).Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S5-8. doi: 10.1097/IGC.0000000000000282. Int J Gynecol Cancer. 2014. PMID: 25341581 Review.
-
Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas.Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S61-6. doi: 10.1097/IGC.0000000000000261. Int J Gynecol Cancer. 2014. PMID: 25341583 Free PMC article. Review.
-
First-line therapy in ovarian cancer trials.Int J Gynecol Cancer. 2011 May;21(4):756-62. doi: 10.1097/IGC.0b013e31821ce75d. Int J Gynecol Cancer. 2011. PMID: 21543937 Review.
Cited by
-
The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer.Radiol Oncol. 2016 Jul 19;50(3):341-6. doi: 10.1515/raon-2016-0034. eCollection 2016 Sep 1. Radiol Oncol. 2016. PMID: 27679552 Free PMC article.
-
Clinical trials with pegylated liposomal Doxorubicin in the treatment of ovarian cancer.J Drug Deliv. 2013;2013:898146. doi: 10.1155/2013/898146. Epub 2013 Mar 14. J Drug Deliv. 2013. PMID: 23577259 Free PMC article.
-
Emerging concerns when evidence-based medicine is translated into real life: the case of neoadjuvant chemotherapy in ovarian cancer.Curr Oncol Rep. 2013 Feb;15(1):4-6. doi: 10.1007/s11912-012-0278-0. Curr Oncol Rep. 2013. PMID: 23054938 No abstract available.
-
Deep learning magnetic resonance imaging predicts platinum sensitivity in patients with epithelial ovarian cancer.Front Oncol. 2022 Nov 23;12:895177. doi: 10.3389/fonc.2022.895177. eCollection 2022. Front Oncol. 2022. PMID: 36505880 Free PMC article.
-
Evaluation of Computed Tomography Scan and CA 125 Response in Predicting Operability in Advanced Ovarian Cancer and Assessing Survival Outcome in Interval Cytoreductive Surgery.Indian J Surg Oncol. 2019 Sep;10(3):426-434. doi: 10.1007/s13193-018-0868-x. Epub 2019 Jan 3. Indian J Surg Oncol. 2019. PMID: 31496584 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical